Australian actor Martin Grelis, who appeared in the 1999 first installment of The Matrix film series, has died at the age of 57. “Martin was a bright spark who lit up every room he was in—a talented ...

We can readily understand why investors are attracted to unprofitable companies. By way of example, Microbot Medical (NASDAQ:MBOT) has seen its share price rise 142% over the last year, delighting ...

Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of November 17, 2025, the average one-year price target for ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

I recently drove the new 2026 Audi Q3 and was amazed by how well-put-together it was, especially for an entry-level crossover from a German luxury automaker. One of the features that stood out was the ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

When it comes to LED matrixes, building one is just the first step. Then you have to decide what to display on it. [panjanek] came up with a relatively flexible answer to this question, building an ...

The alphabet soup of TV terminology is overwhelming enough, but you might have seen a particularly confusing term pop up lately: mini-LED. LEDs are already tiny, so what exactly could the "mini" here ...

We're on our way back to The Matrix. That's the word from Warner Bros Pictures co-chairman/CEOs Mike De Luca and Pam Abdy via Deadline. During a discussion about Warner Bros. reviving IPs, the subject ...

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...